Full Text (PDF)
Review Article

The Contribution of Dr. Gagandeep Kang to the Field of Pediatrics

Rathod Akshay Maroti, Kasumbiwal Ajay H., Lakhe Siddheshwar A, Mundhe Sudarshan R

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Pediatric Education and Research 13((Special Supplement -I)):p 155-157, July-December 2025. | DOI: 10.21088/per.2321.1644.13225.24

How Cite This Article:

Kasumbiwal Ajay H., Lakhe Siddheshwar A., Mundhe Sudarshan R. et al. The Contribution of Dr. Gagandeep Kang to the Field of Pediatrics. Pediatr. Edu. Res. 2025; 13(2): 155-157.

Timeline

Received : December 02, 2025         Accepted : January 05, 2026          Published : December 30, 2025

Abstract

Dr. Gagandeep Kang, one of India’s leading medical scientists, has made transformative contributions to pediatric healthcare, particularly in the field of infectious diseases. Widely known as India’s “vaccine godmother,” she played a pivotal role in the development, clinical trials, and national introduction of the indigenous rotavirus vaccine, Rotavac, significantly reducing childhood diarrheal deaths. Born in Shimla in 1962, and trained at Christian Medical College, Vellore, she built her career around understanding and combating enteric infections affecting underserved children. Her research spans mucosal immunology, gut health, nutrition, and large-scale disease surveillance. Despite challenges such as gender bias, limited resources, and ethical complexities in pediatric trials, Dr. Kang’s perseverance and leadership set new standards for scientific rigor and public health impact in India. As the first Indian woman Fellow of the Royal Society and a globally respected researcher, she exemplifies the integration of scientific innovation, empathy, and ethical responsibility. Her life offers powerful lessons for students on curiosity, collaboration, resilience, and service-oriented science.


References

  • 1.   Kang, G. (2016). Rotavirus vaccines: New developments and future considerations. Nature Reviews Gastroenterology & Hepatology, 13(12), 706–716.
  • 2.   Kang, G., et al. (2005). Epidemiological and laboratory investigations of outbreaks of diarrheal disease in India: implications for control. Journal of Infectious Diseases, 192 (Supplement_1), S26–S31.
  • 3.   John, J., & Kang, G. (2015). Diarrheal diseases in India: current status and future directions. Current Opinion in Infectious Diseases, 28(5), 446–452.
  • 4.   Bhandari, N., et al. (2014). Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomized, double-blind, placebo-controlled trial. The Lancet, 383(9935), 2136–2143.
  • 5.   Infosys Science Foundation. (2016). Dr. Gagandeep Kang – Infosys Prize Laureate for Life Sciences. Link
  • 6.   Royal Society. (2019). Fellowship of the Royal Society: Dr. Gagandeep Kang. Link
  • 7.   Christian Medical College Vellore. (2020). Profiles of alumni: Dr. Gagandeep Kang. Link
  • 8.   The Hindu. (2019). India’s ‘vaccine godmother’: Dr. Gagandeep Kang becomes first Indian woman elected as FRS.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

The authors report no conflicts of interest in this work.


About this article


Cite this article

Kasumbiwal Ajay H., Lakhe Siddheshwar A., Mundhe Sudarshan R. et al. The Contribution of Dr. Gagandeep Kang to the Field of Pediatrics. Pediatr. Edu. Res. 2025; 13(2): 155-157.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
December 02, 2025 January 05, 2026 December 30, 2025

DOI: 10.21088/per.2321.1644.13225.24

Keywords

Pioneer in Pediatric Infectious Diseases ResearchRotavirus vaccine

Article Level Metrics

Last Updated

Sunday 21 June 2026, 15:43:54 (IST)


625

Accesses

6
110
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received December 02, 2025
Accepted January 05, 2026
Published December 30, 2025

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share